Literature DB >> 15021932

[Livedoid vasculopathy with heterozygous factor V Leiden mutation and sticky platelet syndrome].

V Lewerenz1, T Burchardt, A Büchau, T Ruzicka, M Megahed.   

Abstract

A 64-year-old male patient presented with painful ulcerations and livedo racemosa of both lower limbs. He had a history of cerebral and myocardial infarctions. Dermatohistologic findings and laboratory tests of the patient's coagulation system revealed the diagnosis of livedoid vasculopathy with heterozygous factor V Leiden mutation and sticky platelet syndrome type II. Systemic treatment with acetylsalicylic acid and heparin as well as topical therapy with disinfectant and granulation-inducing agents resulted in improvement of the skin lesions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15021932     DOI: 10.1007/s00105-004-0709-4

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  7 in total

1.  Homocysteinemia and livedoid vasculitis.

Authors:  G E Gibson; H Li; M R Pittelkow
Journal:  J Am Acad Dermatol       Date:  1999-02       Impact factor: 11.527

2.  Treatment of livedoid vasculopathy with low-molecular-weight heparin: report of 2 cases.

Authors:  Bethany R Hairston; Mark D P Davis; Lawrence E Gibson; Lisa A Drage
Journal:  Arch Dermatol       Date:  2003-08

3.  Livedoid vasculitis responding to PUVA therapy.

Authors:  J H Lee; H J Choi; S M Kim; S K Hann; Y K Park
Journal:  Int J Dermatol       Date:  2001-02       Impact factor: 2.736

Review 4.  Livedo (livedoid) vasculitis and the factor V Leiden mutation: additional evidence for abnormal coagulation.

Authors:  Kenneth T Calamia; Maria Balabanova; Charles Perniciaro; John S Walsh
Journal:  J Am Acad Dermatol       Date:  2002-01       Impact factor: 11.527

5.  Livedo vasculitis. Segmental hyalinizing vasculitis of the dermis.

Authors:  J W Bard; R K Winkelmann
Journal:  Arch Dermatol       Date:  1967-11

6.  Livedo reticularis and livedoid vasculitis responding to PUVA therapy.

Authors:  H J Choi; S K Hann
Journal:  J Am Acad Dermatol       Date:  1999-02       Impact factor: 11.527

7.  Intractable livedoid vasculopathy successfully treated with hyperbaric oxygen.

Authors:  C-H Yang; H-C Ho; Y-S Chan; L-B Liou; H-S Hong; L-C Yang
Journal:  Br J Dermatol       Date:  2003-09       Impact factor: 9.302

  7 in total
  1 in total

1.  Livedoid vasculopathy associated with combined prothrombin G20210A and factor V (Leiden) heterozygosity and MTHFR C677T homozygosity.

Authors:  Noha A Irani-Hakime; Farid Stephan; Raghid Kreidy; Isabelle Jureidini; Wassim Y Almawi
Journal:  J Thromb Thrombolysis       Date:  2008-03-23       Impact factor: 2.300

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.